Brimonidine Tartrate Impurity 2
Synchemia is a leading supplier in pharmaceutical Brimonidine Impurities . Brimonidine is used to treat ocular hypertension and glaucoma by lowering eye pressure and to manage rosacea to reduce facial redness. It works in the eyes by decreasing the production of fluid within the eye and on the skin by constricting blood vessels. There are different forms for these uses: eye drops for the eyes and gel for the skin.
Brimonidine Tartrate Impurity 2 CAS NO: NA chemically represented as 1-(5-Bromoquinolin-7-yl)thiourea . Brimonidine Tartrate Impurity 2 is supplied with comprehensive characterization data, in full compliance with applicable regulatory guidelines. Synchemia is the leading supplier and exporter of Brimonidine Tartrate Impurity 2 . All Synchemia products are strictly intended for analytical testing purposes only and not for human use.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-B30261 |
| CAS No | 59803-98-4 |
| Mol.F. | C11H10BrN5 |
| Mol.Wt. | 292.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30262 |
| CAS No | 91147-43-2 |
| Mol.F. | C11H11N5 |
| Mol.Wt. | 213.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30263 |
| CAS No | 50358-63-9 |
| Mol.F. | C8H6BrN3 |
| Mol.Wt. | 224.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30264 |
| CAS No | 6298-37-9 |
| Mol.F. | C8H7N3 |
| Mol.Wt. | 145.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30265 |
| CAS No | 842138-74-3 |
| Mol.F. | C9H7BrN4S |
| Mol.Wt. | 283.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30266 |
| CAS No | 168329-48-4 |
| Mol.F. | C9H8BrN5 : C2HF3O2 |
| Mol.Wt. | 266.1 : 114.0g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30267 |
| CAS No | 151110-15-5 |
| Mol.F. | C11H8BrN5 |
| Mol.Wt. | 290.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30268 |
| CAS No | 1216379-05-3 |
| Mol.F. | C11H12BrN5O |
| Mol.Wt. | 310.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30269 |
| CAS No | 91147-46-5 |
| Mol.F. | C11H10ClN5 |
| Mol.Wt. | 247.7g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30270 |
| CAS No | 134892-46-9 |
| Mol.F. | C9H4BrN3S |
| Mol.Wt. | 266.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30271 |
| CAS No | 842138-75-4 |
| Mol.F. | C11H10BrN3OS |
| Mol.Wt. | 312.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30272 |
| CAS No | 182627-95-8 |
| Mol.F. | C11H10BrN5O2 |
| Mol.Wt. | 324.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30273 |
| CAS No | NA |
| Mol.F. | C23H20Br2N10 |
| Mol.Wt. | 596.3g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30274 |
| CAS No | NA |
| Mol.F. | C15H12BrN5O4 |
| Mol.Wt. | 406.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30276 |
| CAS No | 1217439-06-9 |
| Mol.F. | C13H14N4 |
| Mol.Wt. | 226.3g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-B30277 |
| CAS No | NA |
| Mol.F. | C14H14BrN5O2 |
| Mol.Wt. | 364.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |